Attovia Therapeutics, Inc.
ATTO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002058707
In the last 90 days, Attovia Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 65 institutions reported holding it in 13F filings for Q3 2026, worth $693.4M in total; no superinvestor holds it.
Holders of 5% or more of ATTO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Attovia Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 13D | 13.50%6.15M shares | New | Aug 11, 20261 filing | Aug 11, 2026 | SEC |
| venBio Global Strategic Fund IV, L.P. | 13G | 9.20%4.18M shares | New | Nov 16, 20261 filing | Nov 16, 2026 | SEC |
| Deep Track Capital, LP | 13G | 7.45%3.21M shares | New | Aug 12, 20261 filing | Aug 12, 2026 | SEC |
| Alamar HoldCo, LLC | 13G | 7.10%3.23M shares | New | Nov 13, 20261 filing | Nov 13, 2026 | SEC |
| Goldman Sachs Group Inc | 13G | 6.70%3.04M shares | New | Nov 13, 20261 filing | Nov 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Attovia Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20265:26 PM ET | venBio Global Strategic Fund IV, L.P.and 1 other | 13G | 9.20%4.18M shares | New | Sep 30, 2026 | SEC |
| Nov 13, 20265:29 PM ET | Goldman Sachs Group Incand 6 others | 13G | 6.70%3.04M shares | New | Sep 30, 2026 | SEC |
| Nov 13, 20264:19 PM ET | Alamar HoldCo, LLC | 13G | 7.10%3.23M shares | New | Sep 30, 2026 | SEC |
| Aug 12, 20264:02 PM ET | Deep Track Capital, LPand 2 others | 13G | 7.45%3.21M shares | New | Aug 5, 2026 | SEC |
| Aug 11, 20265:08 PM ET | Frazier Life Sciences Public Fund, L.P.and 8 others | 13D | 13.50%6.15M shares | New | Aug 6, 2026 | SEC |
Form 144: proposed insider sales
1 notice from officers, directors and other affiliates planning to sell Attovia Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 28, 20265:50 PM ET | Goldman Sachs Group IncFormer 10% Owner | 105.8K | $2.22M | Aug 5, 2026 | Goldman Sachs & Co. LLC | SEC |